Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2005

01-09-2005 | OTHER RESEARCH ARTICLES

HIV Transmission Behaviors in Jail/Prison Among Puerto Rican Drug Injectors in New York and Puerto Rico

Authors: Sung-Yeon Kang, PhD, Sherry Deren, Jonny Andia, Hector M. Colón, Rafaela Robles, Denise Oliver-Velez

Published in: AIDS and Behavior | Issue 3/2005

Login to get access

Abstract

This study examined HIV risk behavior in jail/prison among Puerto Rican drug injectors in New York (NY, n = 300) and Puerto Rico (PR, n = 200), and its relationship with later drug and sex risk behaviors. During 3 years prior to interview, 66% of NY and 43% of PR samples were incarcerated at least once. While incarcerated, 5% of NY and 53% of PR injected drugs. Few reported engaging in sex inside jail/prison (5% in both sites). Of those who engaged in risk behaviors in jail/prison, almost all reported having unprotected sex and sharing injection equipment. The impact of jail/prison risk behaviors on risk behaviors after release differed between the two sites: they were more related to subsequent sex risk behaviors in NY, and subsequent injection risk behaviors in PR. The findings indicate a need for effective drug treatment programs inside jail/prisons to reduce HIV-related risk behaviors among drug injectors during incarceration and after release.
Literature
Andia, J., Deren, S., Robles, R., Kang, S.-Y., Colón, H. M., Oliver-Velez, D., and Finlinson, A. (in press). Factors associated with injection and non-injection drug use during incarceration among Puerto Rican drug injectors in New York and Puerto Rico. Prison Journal.
Braithwaite, R. L., and Arriola, K. R. J. (2003). Male prisoners and HIV prevention: A call for action ignored. American Journal of Public Health, 93, 759–763.PubMed
Buavirat, A., Page-Shafer, K., van Griensven, G. J. P., Mandel, J. S., Evans, J., Chuaratanaphong, J., Chiamwongpat, S., Sacks, R., and Moss, A. (2003). Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: Case-control study. British Medical Journal, 326, 308–310.PubMedCrossRef
Clarke, J. G., Stein, M. D., Hanna, L., Sobota, M., and Rich, J. D. (2001). Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Substance Abuse, 22, 209–216.CrossRefPubMed
Colón, H. M., Finlinson, H. A., Robles, R. R., Deren, S., Andia, J., Kang, S.-Y., and Oliver-Velez, D. (2001a). Joint drug purchases and drug preparation risk behaviors among Puerto Rican injection drug users. AIDS and Behavior, 5, 85–96.CrossRef
Colón, H. M., Robles, R. R., Deren, S., Sahai, H., Finlinson, H. A., Andia, J., Cruz, M. A., Kang, S.-Y., and Oliver-Velez, D. (2001b). Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico. Journal of Acquired Immune Deficiency Syndromes, 27, 405–413.PubMed
Deren, S., Kang, S.-Y., Colón, H. M., Andia, J., and Robles, R. (2004). HIV incidence among high risk Puerto Rican drug users: A comparison of East Harlem, New York and Bayamón, Puerto Rico. Journal of Acquired Immune Deficiency Syndromes, 36, 1067–1074.
Deren, S., Oliver-Velez, D., Finlinson, A., Robles, R., Andia, J., Colón, H. M., Kang, S.-Y., and Shedlin, M. (2003). Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Substance Use & Misuse, 38, 1–24.CrossRefPubMed
Deren, S., Robles, R., Andia, J., Colón, H. M., Kang, S.-Y., and Perlis, T. (2001). Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992–1999. Journal of Acquired Immune Deficiency Syndromes, 26, 164–169.CrossRefPubMed
Desai, A. A., Latta, E. T., Spaulding, A., Rich, J. D., and Flanigan, T. P. (2002). The importance of routine HIV testing in the incarcerated population: The Rhode Island experience. AIDS Education and Prevention, 14(Supplement B), 45–52.CrossRefPubMed
Dolan, K. A., and Wodak, A. D. (1999). HIV transmission in a prison system in an Australian state. Medical Journal of Australia, 171, 14–17.PubMed
Eigenberg, H. M. (2000). Correctional offices and their perceptions of homosexuality, rape, and prostitution in male prisons. Prison Journal, 4, 415–433.
Estébanez, P., Zunzunegui, M. V., Aguilar, M. D., Russell, N., Cifuentes, I., and Hankins, C. (2002). The role of prisons in the HIV epidemic among female injecting drug users. AIDS Care, 14, 95–104.PubMedCrossRef
Finlinson, H. A., Oliver-Velez, D., Colón, H. M., Deren, S., Robles, R. R., Beardsley, M., Cant, J. G. H., Andia, J., and López, M. S. (2000). Syringe acquisition and use of syringe exchange programs by Puerto Rican drug injectors in New York and Puerto Rico: Comparisons based on quantitative and qualitative methods. AIDS and Behavior, 4, 341–351.CrossRef
Frost, L., and Tchertkov, V. (2002). Prisoner risk taking in the Russian Federation. AIDS Education and Prevention, 14(Suppl. B), 7–23.CrossRefPubMed
Goldberg, D., Taylor, A., McGregor, J., Davis, B., Wrench, J., and Gruer, L. (1998). A lasting public health response to an outbreak of HIV infection in a Scottish prison? International Journal of Sexually Transmitted Diseases and AIDS, 9, 25–30.
Hamid, R., Deren, S., Beardsley, M., and Tortu, S. (1999). Agreement between urinalysis and self-reported drug use. Substance Use & Misuse, 34, 1585–1592.CrossRef
Hammett, T. M., Harmon, P., and Maruschak, L. M. (1999). 1996-1997 update: HIV/AIDS, STDs, and TB in correctional facilities. Washington, DC: U.S. Department of Justice, National Institute of Justice.
Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden population. Social Problems, 44, 174–199.CrossRef
Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 642–654.PubMed
Kang, S.-Y., Deren, S., Andia, J., Colón, H. M., and Robles, R. (2001). Gender differences in HIV risk behaviors among Puerto Rican drug injectors by awareness of HIV seropositive status. AIDS and Behavior, 5, 241–249.CrossRef
Klein, S. J., O'Connell, D. A., Devore, B. S., Wright, L. N., and Birkhead, G. S. (2002). Building an HIV continuum for inmates: New York State's criminal justice initiative. AIDS Education and Prevention, 14(Suppl. B), 114–123.CrossRefPubMed
Krebs, C. P. (2002). High-risk HIV transmission behavior in prison and the prison subculture. Prison Journal, 82, 19–49.CrossRef
Krebs, C. P., and Simmons, M. (2002). Intraprison HIV transmission: An assessment of whether it occurs, how it occurs, and who is at risk. AIDS Education and Prevention, 14(Suppl. B), 53–64.CrossRefPubMed
Latkin, C. A. (1998). Outreach in natural settings: The use of peer leaders for HIV prevention among injection drug users' networks. Public Health Reports, 113(Suppl. 1), 151–159.PubMed
Latkin, C. A., Sherman, S., and Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology, 22, 332–339.CrossRefPubMed
Magura, S., Kang, S.-Y., Shapiro, J. L., and O'Day, J. (1995). Evaluation of an AIDS education model for women drug users in jail. International Journal of the Addiction, 30, 259–273.
Mahon, N. (1996). New York inmates' HIV risk behaviors: The implication for prevention policy and programs. American Journal of Public Health, 86, 1211–1215.PubMed
Maruschak, L. M. (2002). HIV in prisons, 2000 (NCJ No. 196023). Washington, DC: Bureau of Justice Statistics.
May, J. P., and Williams, E. L. Jr., (2002). Acceptability of condom availability in a U.S. jail. AIDS Education and Prevention, 14(Suppl. B), 85–91.CrossRefPubMed
Montoya, I. D., Bell, D. C., Richard, A. J., Carlson, J. W., and Trevino, R. A. (1999). Estimated HIV risk among Hispanics in a national sample of drug users. Journal of Acquired Immune Deficiency Syndromes, 21, 42–50.PubMed
Muller, M., Stark, K., Guggenoos-Holzman, I., Wirth, D., and Beinzle, U. (1995). Imprisonment: A risk factor for HIV infection counteracting behavior and prevention programmes for intravenous drug users. AIDS, 9, 183–190.PubMed
Needle, R., Fisher, D. G., Weatherby, N., Chitwood, D., Brown, B. S., Cesari, H., Booth, R., Williams, M. L., Watters, J., Andersen, M., and Braunstein, M. (1995). The reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9, 242–250.CrossRef
New York City Department of Health (2002). HIV/AIDS: Semi Annual Report. Surveillance Update, including Persons Living with AIDS in New York City. New York: New York City Department of Health, June.
Oliver-Velez, D., Finlinson, H. A., Deren, S., Robles, R. R., Shedlin, M., Andia, J., and Colón, H. M. (2002). Mapping the air bridge locations: The application of ethnographic mapping techniques to a study of HIV risk behavior determinant in East Harlem, New York, and Bayamón, Puerto Rico. Human Organization, 61, 262–276.
Quan, V. M., Steketee, R. W., Valleroy, L., Weinstock, H., Karon, J., and Janssen, R. (2002). HIV incidence in the United States, 1978–1999. Journal of Acquired Immune Deficiency Syndrome, 31, 188–201.
Robles, R. R., Marrero, C. A., Freeman, D. H., Colón, H. M., Matos, T. D., and Sahai, H. (1993). Incarceration history as a risk factor for HIV infection among Puerto Rican injection drug users. PRHS, 12, 13–17.
Robles, R. R., Matos, T. D., Colón, H. M., Deren, S., Reyes, J. C., Andia, J., Marrero, C. A., and Sahai, H. (2003). Determinants of health care use among Puerto Rican drug users in Puerto Rico and New York City. Clinical Infectious Diseases, 37(Suppl. 5), S392–S403.CrossRefPubMed
SAMHSA (2000). Substance Abuse Treatment in Adult and Juvenile Correctional Facilities: Findings from the Uniform Facility Data Set 1977 Survey of Correctional Facilities. Office of Applied Studies. Washington, DC: SAMHSA.
Saum, C., Surratt, H., Inciardi, J., and Bennett, R. (1995). Sex in prison: Exploring the myths and realities. Prison Journal, 75, 413–430.
Struckman-Johnson, C., and Struckman-Johnson, D. (2000). Sexual coercion rates in seven Midwestern prison facilities for men. Prison Journal, 80, 379–390.
Struckman-Johnson, C. and Struckman-Johnson, D., Rucher, L., Bumby, K., and Donaldson, S. (1996). Sexual coercion reported by men and women in prison. Journal of Sex Research, 33, 67–76.CrossRef
Taylor, A., Goldberg, D., Emslie, J., Wrench, J., Gruer, L., Cameron, S., Black, J., Davis, B., McGregor, J., Follett, E., Harvey, J., Basson, J., and McGavigan, J. (1995). Outbreak of HIV infection in a Scottish prison. British Medical Journal, 310, 289–292.PubMed
Watters, J., and Biernacki, P. (1989). Targeted sampling: Options for the study of hidden populations. Social Problems, 6, 416–430.CrossRef
Weatherby, N. L., Needle, R., Cesari, H., Booth, R., McCoy, C. B., Watters, J. K., Williams, M. L., and Chitwood, D. D. (1994). Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning, 17, 347–355.CrossRef
Metadata
Title
HIV Transmission Behaviors in Jail/Prison Among Puerto Rican Drug Injectors in New York and Puerto Rico
Authors
Sung-Yeon Kang, PhD
Sherry Deren
Jonny Andia
Hector M. Colón
Rafaela Robles
Denise Oliver-Velez
Publication date
01-09-2005
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2005
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-005-9011-4

Other articles of this Issue 3/2005

AIDS and Behavior 3/2005 Go to the issue

Other Research Article

Sexual Networks and HIV Risk of People with Severe Mental Illness in Institutional and Community-Based Care

OTHER RESEARCH ARTICLES

Variations in Patterns of Highly Active Antiretroviral Therapy (HAART) Adherence

AIDS PUBLIC POLICY FEATURED ARTICLE

Housing Status and HIV Risk Behaviors: Implications for Prevention and Policy

Behavioral Changes in the Era of Combination Therapies

Predictors of Serostatus Disclosure to Partners Among Young People Living with HIV in the Pre- and Post-HAART Eras

OTHER RESEARCH ARTICLES

Elicitation of Salient Beliefs Related to Drug Preparation Practices Among Injection Drug Users in Puerto Rico

Interpersonal Violence and HIV/AIDS

The Association of Partner Abuse with Risky Sexual Behaviors Among Women and Men with HIV/AIDS
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits